Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital of North Norway
With
UiT The Arctic University of Norway
Age
22–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A MADRS score of =/ \> 20 (moderate depression).
The current depressive episode must have lasted more than 2 weeks but less than 2 years
Drug therapy must have been stable for the last three weeks prior to the first treatment day with iTBS and is to be kept stable throughout the study until 4 weeks after the last day of iTBS treatment.
Patients must volunteer to provide informed consent, be able to follow the treatment schedule and have a satisfactory safety screening for iTBS and MRI.
You may not be if
The current depressive episode is in the mild range or contrary that the current episode fulfills the criteria for a major depressive episode requiring inpatient treatment and/or electroconvulsive therapy.
The current depressive episode is clearly triggered by grief or a recent major stressful life event.
Bipolar disorder.
Borderline personality disorder.
Psychotic symptoms the last 6 months.
Alcohol or substance abuse/addiction in the last 6 months.
Current eating disorders.
Obsessive- compulsive disorders.
Post-traumatic stress disorder.
Any medical history of seizure.
Any neurological or neurosurgical pathologies.
Any current cardiac or systemic disease.
Metallic prosthetic material or foreign objects in the body (pacemakers, internal cardioverter defibrillator units, insulin pump, prosthetic eye equipment, etc.).
Previously diagnosed developmental disorder.
Pregnancy or lactating.
Clareo Health | The Antidepressant Effect of Intermittent Theta Burst Stimulation (iTBS)
